A comprehensive review on the prevention and regulation of Alzheimer’s disease by tea and its active ingredients

References

• Abe, A., A. Nozawa, T. Kakuda, and Y. Yoneda. 2007. Action of theanine on neuronal cell. Nihon Nnougeikagaku Kai 302 (0 16.
   Google Scholar
• Akagawa, M., M. Nakano, and K. Ikemoto. 2016. Recent progress in studies on the health benefits of pyrroloquinoline quinone. Bioscience, Biotechnology, and Biochemistry 80 (1):13–22. doi: 10.1080/09168451.2015.1062715.
   PubMed Web of Science ®Google Scholar
• Akbarialiabad, H., M. D. Dahroud, M. M. Khazaei, S. Razmeh, and M. M. Zarshenas. 2021. Green tea, a medicinal food with promising neurological benefits. Current Neuropharmacology 19 (3): 349–59. doi: 10.2174/1570159X18666200529152625.
   PubMed Web of Science ®Google Scholar
• Alharbi, K. S., O. Afzal, W. H. Almalki, I. Kazmi, M. A. Javed Shaikh, L. Thangavelu, M. Gulati, S. K. Singh, N. K. Jha, P. K. Gupta, et al. 2022. Nuclear factor-kappa B (NF-ΚB) inhibition as a therapeutic target for plant nutraceuticals in mitigating inflammatory lung diseases. Chemico-Biological Interactions 354:109842. doi: 10.1016/j.cbi.2022.109842.
   PubMed Web of Science ®Google Scholar
• Almeida, T., R. J. Rodrigues, A. De Mendonça, J. A. Ribeiro, and R. A. Cunha. 2003. Purinergic P2 receptors trigger adenosine release leading to adenosine A2A receptor activation and facilitation of long-term potentiation in rat hippocampal slices. Neuroscience 122 (1):111–21. doi: 10.1016/S0306-4522(03)00523-2.
   PubMed Web of Science ®Google Scholar
• Alzheimer’s Disease International. 2021. World Alzheimer report 2021. https://www.alzint.org/resource/world-alzheimer-report-2021/.
   Google Scholar
• Anand, A., A. A. Patience, N. Sharma, and N. Khurana. 2017. The present and future of pharmacotherapy of Alzheimer’s disease: A comprehensive review. European Journal of Pharmacology 815:364–75. doi: 10.1016/j.ejphar.2017.09.043.
   PubMed Web of Science ®Google Scholar
• Anand, R., K. D. Gill, and A. A. Mahdi. 2014. Therapeutics of Alzheimer’s disease: Past, present and future. Neuropharmacology 76 (PART A):27–50. doi: 10.1016/j.neuropharm.2013.07.004.
   PubMedGoogle Scholar
• Aranda, J. V., J. M. Collinge, R. Zinman, and G. Watters. 1979. Maturation of caffeine elimination in infancy. Archives of Disease in Childhood 54 (12):946–9. doi: 10.1136/ADC.54.12.946.
   PubMed Web of Science ®Google Scholar
• Arendash, G. W., W. Schleif, K. Rezai-Zadeh, E. K. Jackson, L. C. Zacharia, J. R. Cracchiolo, D. Shippy, and J. Tan. 2006. Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience 142 (4):941–52. doi: 10.1016/J.NEUROSCIENCE.2006.07.021.
   PubMed Web of Science ®Google Scholar
• Arendash, G. W., T. Mori, C. Cao, M. Mamcarz, M. Runfeldt, A. Dickson, K. Rezai-Zadeh, J. Tane, B. A. Citron, X. Lin, et al. 2009. Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer’s disease mice. Journal of Alzheimer’s Disease: JAD 17 (3):661–80. doi: 10.3233/JAD-2009-1087.
   PubMed Web of Science ®Google Scholar
• Arnaud, M. J. 1987. The pharmacology of caffeine. In Progress in Drug Research/Fortschritte Der Arzneimittelforschung/Progrès Des Recherches Pharmaceutiques, edited by Ernst Jucker and Urs Meyer, 273–313. Basel: Birkhäuser Basel. doi: 10.1007/978-3-0348-9289-6_9.
   Google Scholar
• Bansal, S., S. Choudhary, M. Sharma, S. S. Kumar, S. Lohan, V. Bhardwaj, N. Syan, and S. Jyoti. 2013. Tea: A native source of antimicrobial agents. Food Research International 53 (2):568–84. doi: 10.1016/j.foodres.2013.01.032.
   Web of Science ®Google Scholar
• Bao, J., W. Liu, H. Zhou, Y. Gui, Y. Yang, M. Wu, Y. Xiao, J. Shang, G. Long, and X. Shu. 2020. Epigallocatechin-3-gallate alleviates cognitive deficits in APP/PS1 mice. Current Medical Science 40 (1):18–27. doi: 10.1007/s11596-020-2142-z.
   PubMed Web of Science ®Google Scholar
• Bars, P., M. Kieser, and K. Z. Itil. 2000. A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract egb 761 in dementia. Dementia & Geriatric Cognitive Disorders, 11(4):230–7.
   PubMed Web of Science ®Google Scholar
• Ben, P., Z. Zhang, Y. Zhu, A. Xiong, Y. Gao, J. Mu, Z. Yin, and L. Luo. 2016. L-Theanine attenuates cadmium-induced neurotoxicity through the inhibition of oxidative damage and tau hyperphosphorylation. Neurotoxicology 57:95–103. doi: 10.1016/j.neuro.2016.09.010.
   PubMed Web of Science ®Google Scholar
• Biasibetti, R., A. C. Tramontina, A. P. Costa, M. F. Dutra, A. Quincozes-Santos, P. Nardin, C. L. Bernardi, K. M. Wartchow, P. S. Lunardi, and C. A. Gonçalves. 2013. Green tea (-)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia. Behavioural Brain Research 236 (1):186–93. doi: 10.1016/j.bbr.2012.08.039.
   PubMedGoogle Scholar
• Block, M. L., and J.-S. Hong. 2005. Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism. Progress in Neurobiology 76 (2):77–98. doi: 10.1016/j.pneurobio.2005.06.004.
   PubMed Web of Science ®Google Scholar
• Bokelmann, J. M. 2022. 24 - Aloe (Aloe Vera, Aloe Barbardensis): leaf and leaf pulp. Vol. 24. In Medicinal Herbs in Primary Care Bokelmann, ed. M. B. T. Jean, 179–87. Elsevier. doi: 10.1016/B978-0-323-84676-9.00024-6.
   Google Scholar
• Bond and Derbyshire . 2019. Tea Compounds and the Gut Microbiome: Findings from Trials and Mechanistic Studies. Nutrients 11 (10):2364. doi:10.3390/nu11102364.
   PubMed Web of Science ®Google Scholar
• Bonfili, L., V. Cecarini, S. Berardi, S. Scarpona, J. S. Suchodolski, C. Nasuti, D. Fiorini, M. C. Boarelli, G. Rossi, and A. M. Eleuteri. 2017. Microbiota modulation counteracts Alzheimer’s disease progression influencing neuronal proteolysis and gut hormones plasma levels. Scientific Reports 7 (1):2426. doi: 10.1038/s41598-017-02587-2.
   PubMed Web of Science ®Google Scholar
• Borzelleca, J. F., D. Peters, and W. Hall. 2006. A 13-week dietary toxicity and toxicokinetic study with L-theanine in rats. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 44 (7):1158–66. doi: 10.1016/j.fct.2006.03.014.
   PubMed Web of Science ®Google Scholar
• Bostanciklioğlu, M. 2019. The role of gut microbiota in pathogenesis of Alzheimer’s disease. Journal of Applied Microbiology 127 (4):954–67. doi: 10.1111/jam.14264.
   PubMed Web of Science ®Google Scholar
• Bowery, N. G., and T. G. Smart. 2006. GABA and glycine as neurotransmitters: A brief history. British Journal of Pharmacology 147 (S1):S109–S19. doi: 10.1038/sj.bjp.0706443.
   PubMedGoogle Scholar
• Broom, G. M., I. C. Shaw, and J. J. Rucklidge. 2019. The ketogenic diet as a potential treatment and prevention strategy for Alzheimer’s disease. Nutrition (Burbank, Los Angeles County, CA) 60:118–21. doi: 10.1016/j.nut.2018.10.003.
   PubMed Web of Science ®Google Scholar
• Browne, S. E., and M. F. Beal. 1994. Oxidative damage and mitochondrial dysfunction in neurodegenerative diseases. Biochemical Society Transactions 22 (4):1002–6. doi: 10.1042/bst0221002.
   PubMed Web of Science ®Google Scholar
• Dragicevic, N., V. Delic, C. Cao, N. Copes, X. Lin, M. Mamcarz, L. Wang, G. W. Arendash, and P. C. Bradshaw. 2012. Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer’s mice and cells. Neuropharmacology 63 (8):1368–79. doi: 10.1016/j.neuropharm.2012.08.018.
   PubMed Web of Science ®Google Scholar
• Cao, C., J. R. Cirrito, X. Lin, L. Wang, D. K. Verges, A. Dickson, M. Mamcarz, et al. 2009. Caffeine suppresses amyloid-β levels in plasma and brain of Alzheimer’s disease transgenic mice. Journal of Alzheimer’s Disease 17:681–97. doi: 10.3233/JAD-2009-1071.
   PubMed Web of Science ®Google Scholar
• Cao, C., L. Wang, X. Lin, M. Mamcarz, C. Zhang, G. Bai, J. Nong, S. Sussman, and G. Arendash. 2011. Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer’s mice. Journal of Alzheimer’s Disease 25: 323–35. doi: 10.3233/JAD-2011-110110.
   PubMed Web of Science ®Google Scholar
• Carver, K. A., D. Lourim, A. K. Tryba, and D. R. Harder. 2014. Rhythmic expression of cytochrome P450 epoxygenases CYP4x1 and CYP2c11 in the rat brain and vasculature. American Journal of Physiology. Cell Physiology 307 (11):C989–98. doi: 10.1152/ajpcell.00401.2013.
   PubMed Web of Science ®Google Scholar
• Carmichael, O. T., S. Pillai, P. Shankapal, A. McLellan, D. G. Kay, B. T. Gold, and J. N. Keller. 2018. A combination of essential fatty acids, panax ginseng extract, and green tea catechins modifies brain FMRI signals in healthy older adults. The Journal of Nutrition, Health & Aging 22 (7):837–46. doi: 10.1007/s12603-018-1028-2.
   PubMed Web of Science ®Google Scholar
• Cattaneo, A., N. Cattane, S. Galluzzi, S. Provasi, N. Lopizzo, C. Festari, C. Ferrari, U. P. Guerra, B. Paghera, C. Muscio, et al. 2017. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiology of Aging 49:60–8. doi: 10.1016/j.neurobiolaging.2016.08.019.
   PubMed Web of Science ®Google Scholar
• Cen, Y., X. Zou, Q. Zhong, Y. Chen, Y. Lin, Q. Feng, X. Wang, and S. Zheng. 2022. The TIAR-mediated Nrf2 response to oxidative stress is mediated through the Nrf2 noncoding 3’untranslated region in Spodoptera litura. Free Radical Biology and Medicine 184:17–29. doi: 10.1016/j.freeradbiomed.2022.03.016.
   PubMed Web of Science ®Google Scholar
• Chang, X., C. Rong, Y. Chen, C. Yang, Q. Hu, Y. Mo, C. Zhang, X. Gu, L. Zhang, W. He, et al. 2015. (-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer’s disease model mice by upregulating neprilysin expression. Experimental Cell Research 334 (1):136–45. doi: 10.1016/j.yexcr.2015.04.004.
   PubMed Web of Science ®Google Scholar
• Chen, S.-Q., Z.-S. Wang, Y.-X. Ma, W. Zhang, J.-L. Lu, Y.-R. Liang, and X.-Q. Zheng. 2018. Neuroprotective effects and mechanisms of tea bioactive components in neurodegenerative diseases. Molecules 23 (3):512. doi: 10.3390/molecules23030.
   Web of Science ®Google Scholar
• Chen, Q., J. Shi, B. Mu, Z. Chen, W. Dai, and Z. Lin. 2020. Metabolomics combined with proteomics provides a novel interpretation of the changes in nonvolatile compounds during white tea processing. Food Chemistry 332:127412. doi: 10.1016/j.foodchem.2020.127412.
   PubMed Web of Science ®Google Scholar
• Chen, T., and C. Yang. 2020. Biological fates of tea polyphenols and their interactions with microbiota in the gastrointestinal tract: Implications on health effects. Critical Reviews in Food Science and Nutrition 60 (16):2691–19. doi: 10.1080/10408398.2019.1654430.
   PubMed Web of Science ®Google Scholar
• Chen, T., Y. Yang, S. Zhu, Y. Lu, L. Zhu, Y. Wang, and X. Wang. 2020. Inhibition of Aβ aggregates in Alzheimer’s disease by epigallocatechin and epicatechin-3-gallate from green tea. Bioorganic Chemistry 105 (December):104382. doi: 10.1016/J.BIOORG.2020.104382.
   PubMedGoogle Scholar
• Chhatwal, J. P., S. A. Schultz, E. McDade, A. P. Schultz, L. Liu, B. J. Hanseeuw, N. Joseph-Mathurin, R. Feldman, C. D. Fitzpatrick, K. P. Sparks, et al. 2022. Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer’s disease: Cross-sectional and longitudinal analyses of an observational study. The Lancet Neurology 21 (2):140–52. doi: 10.1016/S1474-4422(21)00375-6.
   PubMed Web of Science ®Google Scholar
• Choi, Y. T., C. H. Jung, S. R. Lee, J. H. Bae, W. K. Baek, M. H. Suh, J. Park, C. W. Park, and S. Il Suh. 2001. The green tea polyphenol (-)-epigallocatechin gallate attenuates β-amyloid-induced neurotoxicity in cultured hippocampal neurons. Life Sciences 70 (5):603–14. doi: 10.1016/S0024-3205(01)01438-2.
   PubMed Web of Science ®Google Scholar
• Chu, Y.-F., W.-H. Chang, R. M. Black, J.-R. Liu, P. Sompol, Y. Chen, H. Wei, Q. Zhao, and I. H. Cheng. 2012. Crude caffeine reduces memory impairment and amyloid Β1–42 levels in an Alzheimer’s mouse model. Food Chemistry 135 (3):2095–102. doi: 10.1016/j.foodchem.2012.04.148.
   PubMed Web of Science ®Google Scholar
• Chu, C.-Q., L. Yu, G. Qi, Y.-S. Mi, W.-Q. Wu, Y. Lee, Q.-X. Zhai, F.-W. Tian, and W. Chen. 2022. Can dietary patterns prevent cognitive impairment and reduce Alzheimer’s disease risk: Exploring the underlying mechanisms of effects. Neuroscience and Biobehavioral Reviews 135:104556. doi: 10.1016/j.neubiorev.2022.104556.
   PubMed Web of Science ®Google Scholar
• Cicero, A. F. G., F. Fogacci, and M. Banach. 2018. Botanicals and phytochemicals active on cognitive decline: The clinical evidence. Pharmacological Research 130:204–12. doi: 10.1016/j.phrs.2017.12.029.
   PubMed Web of Science ®Google Scholar
• Cunha, R. A., P. Correia-de-Sá, A. M. Sebastião, and J. A. Ribeiro. 1996. Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides. British Journal of Pharmacology 119 (2):253–60. doi: 10.1111/J.1476-5381.1996.TB15979.X.
   PubMed Web of Science ®Google Scholar
• Deng, W. W., S. Ogita, and H. Ashihara. 2010. Distribution and biosynthesis of theanine in Theaceae plants. Plant Physiology and Biochemistry 48 (1):70–2. doi: 10.1016/j.plaphy.2009.09.009.
   PubMed Web of Science ®Google Scholar
• Di, X., J. Yan, Y. Zhao, J. Zhang, Z. Shi, Y. Chang, and B. Zhao. 2010. L-Theanine protects the APP (Swedish mutation) transgenic SH-SY5Y cell against glutamate-induced excitotoxicity via inhibition of the NMDA receptor pathway. Neuroscience 168 (3):778–86. doi: 10.1016/j.neuroscience.2010.04.019.
   PubMed Web of Science ®Google Scholar
• Dias, R. B., D. M. Rombo, J. A. Ribeiro, J. M. Henley, and A. M. Sebastião. 2013. Adenosine: Setting the stage for plasticity. Trends in Neurosciences 36 (4):248–57. doi: 10.1016/J.TINS.2012.12.003.
   PubMed Web of Science ®Google Scholar
• Du, K., M. Liu, X. Zhong, W. Yao, Q. Xiao, Q. Wen, B. Yang, and M. Wei. 2018. Epigallocatechin gallate reduces amyloid β-induced neurotoxicity via inhibiting endoplasmic reticulum stress-mediated apoptosis. Molecular Nutrition & Food Research 62 (8):e1700890. doi: 10.1002/mnfr.201700890.
   PubMed Web of Science ®Google Scholar
• Du, X., X. Wang, and M. Geng. 2018. Alzheimer’s disease hypothesis and related therapies. Translational Neurodegeneration 7 (1):2. doi: 10.1186/s40035-018-0107-y.
   PubMedGoogle Scholar
• Edwards, F. A. 2019. A unifying hypothesis for Alzheimer’s disease: From plaques to neurodegeneration. Trends in Neurosciences 42 (5):310–22. doi: 10.1016/j.tins.2019.03.003.
   PubMed Web of Science ®Google Scholar
• Einöther, S. J. L., V. E. G. Martens, J. A. Rycroft, and E. A. De Bruin. 2010. L-Theanine and caffeine improve task switching but not intersensory attention or subjective alertness. Appetite 54 (2):406–9. doi: 10.1016/j.appet.2010.01.003.
   PubMed Web of Science ®Google Scholar
• Eskelinen, M. H., T. Ngandu, J. Tuomilehto, H. Soininen, and M. Kivipelto. 2009. Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. Journal of Alzheimer’s Disease 16:85–91. doi: 10.3233/JAD-2009-0920.
   PubMed Web of Science ®Google Scholar
• Feng, L., X. Gwee, E.-H. Kua, and T.-P. Ng. 2010. Cognitive function and tea consumption in community dwelling older Chinese in Singapore. The Journal of Nutrition, Health & Aging 14 (6):433–8. doi: 10.1007/s12603-010-0095-9.
   PubMed Web of Science ®Google Scholar
• Feng, L., T.-P. Ng, M. Niti, E. H. Kua, and K.-B. Yap. 2008. P4-020: Tea consumption and cognitive impairment and decline. Alzheimer’s & Dementia 4 (4S_Part_21):T673–T673. doi: 10.1016/j.jalz.2008.05.2084.
   Google Scholar
• Fine, A., C. Hoyle, C. J. Maclean, T. L. LeVatte, H. F. Baker, and R. M. Ridley. 1997. Learning impairments following injection of a selective cholinergic immunotoxin, ME20.4 IgG-Saporin, into the basal nucleus of Meynert in monkeys. Neuroscience 81 (2):331–43. doi: 10.1016/S0306-4522(97)00208-X.
   PubMed Web of Science ®Google Scholar
• Fischer, K., D. Melo van Lent, S. Wolfsgruber, L. Weinhold, L. Kleineidam, H. Bickel, M. Scherer, et al. 2018. Prospective associations between single foods, Alzheimer’s dementia and memory decline in the elderly. Nutrients, 10(7), 852. doi: 10.3390/nu10070852.
   PubMed Web of Science ®Google Scholar
• Fredholm, B. B., K. Bättig, J. Holmén, A. Nehlig, and E. E. Zvartau. 1999. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacological Reviews 51 (1):83–133. https://www.scopus.com/inward/record.uri?eid=2-s2.0-0345561561&partnerID=40&md5=e1a4efd15f07f5f09093965990387797.
   PubMed Web of Science ®Google Scholar
• Fuhrer, T. E., T. H. Palpagama, H. J. Waldvogel, B. J. L. Synek, C. Turner, R. L. Faull, and A. Kwakowsky. 2017. Impaired expression of GABA transporters in the human Alzheimer’s disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus. Neuroscience 351:108–18. doi: 10.1016/j.neuroscience.2017.03.041.
   PubMed Web of Science ®Google Scholar
• Fung, T. C., C. A. Olson, and E. Y. Hsiao. 2017. Interactions between the microbiota, immune and nervous systems in health and disease. Nature Neuroscience 20 (2):145–55. doi: 10.1038/nn.4476.
   PubMed Web of Science ®Google Scholar
• Gao, H.-R., Z.-X. Huang and H.-M. Li. 2016. Comparative study on the content of tea polyphenols of sixteen kinds of China tea. Food Research and Development, CHINA 37 (7):33–6. doi: 10.3969/j.issn.1005-6521.2016.07.008.
   Google Scholar
• Gao, Y., Y. Xu, and J. Yin. 2020. Black tea benefits short-chain fatty acid producers but inhibits genus Lactobacillus in the gut of healthy Sprague–Dawley Rats. Journal of the Science of Food and Agriculture 100 (15):5466–75. doi: 10.1002/jsfa.10598.
   PubMed Web of Science ®Google Scholar
• Gelder, B. M. v., B. Buijsse, M. Tijhuis, S. Kalmijn, S. Giampaoli, A. Nissinen, and D. Kromhout. 2007. Coffee consumption is inversely associated with cognitive decline in elderly European men: The FINE study. European Journal of Clinical Nutrition 61 (2):226–32. doi: 10.1038/sj.ejcn.1602495.
   PubMed Web of Science ®Google Scholar
• Goehler, L. E., R. P. A. Gaykema, N. Opitz, R. Reddaway, N. Badr, and M. Lyte. 2005. Activation in vagal afferents and central autonomic pathways: Early responses to intestinal infection with Campylobacter jejuni. Brain, Behavior, and Immunity 19 (4):334–44. doi: 10.1016/j.bbi.2004.09.002.
   PubMed Web of Science ®Google Scholar
• Gołembiowska, K., and A. Dziubina. 2012. The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2. Neurotoxicity Research 22 (2):150–7. doi: 10.1007/s12640-012-9316-9.
   PubMed Web of Science ®Google Scholar
• Goncalves, P. B., A. C. R. Sodero, and Y. Cordeiro. 2021. Green tea epigallocatechin-3-gallate (EGCG) targeting protein misfolding in drug discovery for neurodegenerative diseases. Biomolecules 11 (5):767. doi: 10.3390/biom11050767.
   PubMed Web of Science ®Google Scholar
• Graham, H. N. 1992. Green tea composition, consumption, and polyphenol chemistry. Preventive Medicine 21 (3):334–50. doi: 10.1016/0091-7435(92)90041-F.
   PubMed Web of Science ®Google Scholar
• Grant, W. B. 2014. Trends in diet and Alzheimer’s disease during the nutrition transition in Japan and developing countries. Journal of Alzheimer’s Disease: JAD 38 (3):611–20. doi: 10.3233/JAD-130719.
   PubMed Web of Science ®Google Scholar
• Gu, Y.-J., C.-H. He, S. Li, S.-Y. Zhang, S.-Y. Duan, H.-P. Sun, Y.-P. Shen, Y. Xu, J.-Y. Yin, and C.-W. Pan. 2018. Tea consumption is associated with cognitive impairment in older Chinese adults. Aging & Mental Health 22 (9):1237–43. doi: 10.1080/13607863.2017.1339779.
   Web of Science ®Google Scholar
• Gueli, M. C., and G. Taibi. 2013. Alzheimer’s disease: Amino acid levels and brain metabolic status. Neurological Sciences 34 (9):1575–9. doi: 10.1007/s10072-013-1289-9.
   PubMed Web of Science ®Google Scholar
• Guo, T., W. Noble, and D. P. Hanger. 2017. Roles of tau protein in health and disease. Acta Neuropathologica 133 (5):665–704. doi: 10.1007/s00401-017-1707-9.
   PubMed Web of Science ®Google Scholar
• Guo, Y., Y. Zhao, Y. Nan, X. Wang, Y. Chen, and S. Wang. 2017. (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer’s disease. Neuroreport 28 (10):590–7. doi: 10.1097/wnr.0000000000000803.
   PubMed Web of Science ®Google Scholar
• Gurwara, S., A. Dai, N. Ajami, H. El-Serag, D. Graham, and L. Jiao. 2019. Caffeine consumption and the colonic mucosa-associated gut microbiota. American Journal of Gastroenterology. doi: 10.14309/01.ajg.0000590316.43252.64.
   Web of Science ®Google Scholar
• Haam, J., and J. L. Yakel. 2017. Cholinergic modulation of the hippocampal region and memory function. Journal of Neurochemistry 142 (S2):111–21. doi: 10.1111/jnc.14052.
   PubMedGoogle Scholar
• Hang, Z., T. Lei, Z. Zeng, S. Cai, W. Bi, and H. Du. 2022. Composition of intestinal flora affects the risk relationship between Alzheimer’s disease/Parkinson’s disease and cancer. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 145:112343. doi: 10.1016/j.biopha.2021.112343.
   PubMed Web of Science ®Google Scholar
• Han, K., N. Jia, J. Li, L. Yang, and L.-Q. Min. 2013. Chronic caffeine treatment reverses memory impairment and the expression of brain BNDF and TrkB in the PS1/APP double transgenic mouse model of Alzheimer’s disease. Molecular Medicine Reports 8 (3):737–40. doi: 10.3892/mmr.2013.1601.
   PubMed Web of Science ®Google Scholar
• Haran, J. P., S. K. Bhattarai, S. E. Foley, P. Dutta, D. V. Ward, V. Bucci, and B. A. McCormick. 2022. Alzheimer’s disease microbiome is associated with dysregulation of the anti-inflammatory P-glycoprotein pathway. MBio 10 (3):e00632–19. doi: 10.1128/mBio.00632-19.
   Google Scholar
• Hayat, K., H. Iqbal, U. Malik, U. Bilal, and S. Mushtaq. 2015. Tea and its consumption: Benefits and risks. Critical Reviews in Food Science and Nutrition 55 (7):939–54. doi: 10.1080/10408398.2012.678949.
   PubMed Web of Science ®Google Scholar
• He, J., J. Chen, Q. He, S. Li, L. Jian, F. Xie, C. Dong, G. Bai, Z. Wang, T. Zou, et al. 2021. Oral L-theanine administration promotes fat browning and prevents obesity in mice fed high-fat diet associated with the modulation of gut microbiota. Journal of Functional Foods 81 (June):104476. doi: 10.1016/j.jff.2021.104476.
   Google Scholar
• He, M., M.-Y. Liu, S. Wang, Q.-S. Tang, W.-F. Yao, H.-S. Zhao, and M.-J. Wei. 2012. Research on EGCG improving the degenerative changes of the brain in AD model mice induced with chemical drugs. Zhong Yao Cai = Zhongyaocai = Journal of Chinese Medicinal Materials 35 (10):1641–4. http://europepmc.org/abstract/MED/23627134.
   PubMedGoogle Scholar
• Hilal, Y., and U. Engelhardt. 2007. Characterisation of white tea – comparison to green and black tea. Journal Für Verbraucherschutz Und Lebensmittelsicherheit 2 (4):414–21. doi: 10.1007/s00003-007-0250-3.
   Web of Science ®Google Scholar
• Hill, E., A. M. Goodwill, A. Gorelik, and C. Szoeke. 2019. Diet and biomarkers of Alzheimer’s disease: A systematic review and meta-analysis. Neurobiology of Aging 76:45–52. doi: 10.1016/j.neurobiolaging.2018.12.008.
   PubMed Web of Science ®Google Scholar
• Hu, H.-Y., B.-S. Wu, Y.-N. Ou, Y.-H. Ma, Y.-Y. Huang, W. Cheng, L. Tan, and J.-T. Yu. 2022. Tea consumption and risk of incident dementia: a prospective cohort study of 377 592 UK biobank participants. Translational Psychiatry 12 (1):171. doi: 10.1038/s41398-022-01923-z.
   PubMed Web of Science ®Google Scholar
• Huang, W. J., X. Zhang, and W. W. Chen. 2016. Role of oxidative stress in Alzheimer’s disease. Biomedical Reports 4 (5):519–22. doi:10.3892/BR.2016.630/HTML.
   PubMed Web of Science ®Google Scholar
• Ide, K., Y. Kawasaki, K. Kawakami, and H. Yamada. 2018. Chapter 5 - Effects of bioactive components of green tea on Alzheimer’s disease. In Studies in natural products chemistry, ed. Atta-ur-Rahman, vol. 56, 151–72. The Netherlands: Elsevier. doi: 10.1016/B978-0-444-64058-1.00005-4.
   Google Scholar
• Iqbal, K., F. Liu, C. X. Gong, and I. Grundke-Iqbal. 2010. Tau in Alzheimer disease and related tauopathies. Current Alzheimer Research 7 (8):656–64. doi: 10.2174/156720510793611592.
   PubMed Web of Science ®Google Scholar
• Jang, H.-S., J. Y. Jung, I.-S. Jang, K.-H. Jang, S.-H. Kim, J.-H. Ha, K. Suk, and M.-G. Lee. 2012. L-Theanine partially counteracts caffeine-induced sleep disturbances in rats. Pharmacology, Biochemistry, and Behavior 101 (2):217–21. doi: 10.1016/j.pbb.2012.01.011.
   PubMed Web of Science ®Google Scholar
• Janle, E. M., D. M. Morré, D. J. Morré, Q. Zhou, and Y. Zhu. 2008. Pharmacokinetics of green tea catechins in extract and sustained-release preparations. Journal of Dietary Supplements 5 (3):248–63. doi: 10.1080/19390210802414279.
   PubMedGoogle Scholar
• Jeon, S. G., S. B. Hong, Y. Nam, J. Tae, A. Yoo, E. J. Song, K. I. Kim, D. Lee, J. Park, S. M. Lee, et al. 2019. Ghrelin in Alzheimer’s disease: Pathologic roles and therapeutic implications. Ageing Research Reviews 55:100945. doi: 10.1016/j.arr.2019.100945.
   PubMed Web of Science ®Google Scholar
• Jia, N., K. Han, J.-J. Kong, X.-M. Zhang, S. Sha, G.-R. Ren, and Y.-P. Cao. 2013. (−) (-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus. Molecular and Cellular Biochemistry 380 (1–2):211–8. doi: 10.1007/s11010-013-1675-x.
   PubMed Web of Science ®Google Scholar
• Jiang, H., F. Yu, L. Qin, N. Zhang, Q. Cao, W. Schwab, D. Li, and C. Song. 2019. Dynamic change in amino acids, catechins, alkaloids, and gallic acid in six types of tea processed from the same batch of fresh tea (Camellia Sinensis L.) leaves. Journal of Food Composition and Analysis 77:28–38. doi: 10.1016/j.jfca.2019.01.005.
   Web of Science ®Google Scholar
• Jiménez-Balado, J., and T. S. Eich. 2021. GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer’s disease. Seminars in Cell & Developmental Biology 116:146–59. doi: 10.1016/j.semcdb.2021.01.005.
   PubMed Web of Science ®Google Scholar
• Jo, M.-R., M.-H. Park, D.-Y. Choi, D.-Y. Yuk, Y.-M. Lee, J.-M. Lee, J.-H. Jeong, et al. 2011. Neuroprotective effect of L-theanine on a beta-induced neurotoxicity through anti-oxidative mechanisms in SK-N-SH and SK-N-MC cells. Biomolecules and Therapeutics 19 (July). doi: 10.4062/biomolther.2011.19.3.288.
   Google Scholar
• Jo, S., O. Yarishkin, Y. J. Hwang, Y. E. Chun, M. Park, D. H. Woo, J. Y. Bae, T. Kim, J. Lee, H. Chun, et al. 2014. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer’s disease. Nature Medicine 20 (8):886–96. doi: 10.1038/nm.3639.
   PubMed Web of Science ®Google Scholar
• Kakuda, T. 2011. Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction. Pharmacological Research 64 (2):162–8. doi: 10.1016/j.phrs.2011.03.010.
   PubMed Web of Science ®Google Scholar
• Kakuda, T., E. Hinoi, A. Abe, A. Nozawa, M. Ogura, and Y. Yoneda. 2008. Theanine, an ingredient of green tea, inhibits [3H] glutamine transport in neurons and astroglia in rat brain. Journal of Neuroscience Research 86 (8):1846–56. doi: 10.1002/jnr.21637.
   PubMed Web of Science ®Google Scholar
• Kim, T. I., Y. K. Lee, S. G. Park, I. S. Choi, J. O. Ban, H. K. Park, S.-Y. Nam, Y. W. Yun, S. B. Han, K. W. Oh, et al. 2009. L-Theanine, an amino acid in green tea, attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity: Reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways. Free Radical Biology & Medicine 47 (11):1601–10. doi: 10.1016/j.freeradbiomed.2009.09.008.
   PubMed Web of Science ®Google Scholar
• Kim, T. I., D. Y. Yuk, S. G. Park, H. K. Park, Y. K. Yoon, K. W. Oh, and J. T. Hong. 2008. Improvement of memory impairment by the combination of green tea extract and L-theanine through inhibition of acetylcholinesterase activity in mice TT. Laboratory Animal Research 24:87–92. http://www.dbpia.co.kr/journal/articleDetail?nodeId=NODE01001107.
   Google Scholar
• Kim, Y., H. Choi, W. Kim, S. Park, D. Lee, D. K. Kim, H. J. Kim, et al. 2020. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model. Gut 69 (2):283–94. doi: 10.1136/gutjnl-2018-317431.
   PubMed Web of Science ®Google Scholar
• Kim, Y.-S., S. M. Kwak, and S.-K. Myung. 2015. Caffeine Intake from coffee or tea and cognitive disorders: A meta-analysis of observational studies. Neuroepidemiology 44 (1):51–63. doi: 10.1159/000371710.
   PubMed Web of Science ®Google Scholar
• Kitaoka, S., H. Hayashi, H. Yokogoshi, and Y. Suzuki. 1996. Transmural potential changes associated with the in vitro absorption of theanine in the guinea pig intestine. Bioscience, Biotechnology, and Biochemistry 60 (11):1768–71. doi: 10.1271/bbb.60.1768.
   PubMed Web of Science ®Google Scholar
• Kitamura, K., Y. Watanabe, K. Nakamura, K. Sanpei, M. Wakasugi, A. Yokoseki, O. Onodera, et al. 2016. Modifiable factors associated with cognitive impairment in 1,143 Japanese outpatients: The Project in Sado for Total Health (PROST). Dementia and Geriatric Cognitive Disorders Extra 6 (2):341–9. doi: 10.1159/000447963.
   PubMedGoogle Scholar
• Kojima, S., and Y. Yoshida. 2008. Effects of green tea powder feed supplement on performance of hens in the late stage of laying. International Journal of Poultry Science 7 (5):491–6. doi: 10.3923/ijps.2008.
   Google Scholar
• Košir, R., K. Španinger, and D. Rozman. 2013. Circadian events in human diseases and in cytochrome P450-related drug metabolism and therapy. IUBMB Life 65 (6):487–96. doi: 10.1002/IUB.1160.
   PubMed Web of Science ®Google Scholar
• Kuriyama, S., A. Hozawa, K. Ohmori, T. Shimazu, T. Matsui, S. Ebihara, S. Awata, R. Nagatomi, H. Arai, and I. Tsuji. 2006. Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1. The American Journal of Clinical Nutrition 83 (2): 355–61. doi: 10.1093/ajcn/83.2.355.
   PubMed Web of Science ®Google Scholar
• Laurent, C., S. Eddarkaoui, M. Derisbourg, A. Leboucher, D. Demeyer, S. Carrier, M. Schneider, et al. 2014. Beneficial effects of caffeine in a transgenic model of Alzheimer’s disease-like tau pathology. Neurobiology of Aging 35 (9):2079–90. doi: 10.1016/j.neurobiolaging.2014.03.027.
   PubMed Web of Science ®Google Scholar
• Lee, J. W., Y. K. Lee, J. O. Ban, T. Y. Ha, Y. P. Yun, S. B. Han, K. W. Oh, and J. T. Hong. 2009. Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice. The Journal of Nutrition 139 (10):1987–93. doi: 10.3945/jn.109.109785.
   PubMed Web of Science ®Google Scholar
• Lee, Y. J., D. Y. Choi, Y. P. Yun, S. B. Han, K. W. Oh, and J. T. Hong. 2013. Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties. The Journal of Nutritional Biochemistry 24 (1):298–310. doi: 10.1016/j.jnutbio.2012.06.011.
   PubMed Web of Science ®Google Scholar
• Levites, Y., T. Amit, S. Mandel, and M. B. H. Youdim. 2003. Neuroprotection and neurorescue against Aβ toxicity and PKC-dependent release of non-amyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. The FASEB Journal 17 (8):1–23. doi: 10.1096/fj.02-0881fje.
   PubMedGoogle Scholar
• Li, R., Y.-G. Huang, D. Fang, and W.-D. Le. 2004. (−) (-)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury. Journal of Neuroscience Research 78 (5):723–31. doi: 10.1002/jnr.20315.
   PubMed Web of Science ®Google Scholar
• Li, Y., S. U. Rahman, Y. Huang, Y. Zhang, P. Ming, L. Zhu, X. Chu, et al. 2020. Green tea polyphenols decrease weight gain, ameliorate alteration of gut microbiota, and mitigate intestinal inflammation in canines with high-fat-diet-induced obesity. The Journal of Nutritional Biochemistry 78:108324. doi: 10.1016/j.jnutbio.2019.108324.
   Google Scholar
• Liu, Y., L. Luo, Y. Luo, J. Zhang, X. Wang, K. Sun, and L. Zeng. 2020. Prebiotic properties of green and dark tea contribute to protective effects in chemical-induced colitis in mice: a fecal microbiota transplantation study. Journal of Agricultural and Food Chemistry 68 (23):6368–80. doi: 10.1021/acs.jafc.0c02336.
   PubMed Web of Science ®Google Scholar
• Liang, J., H. Yan, P. Puligundla, X. Gao, Y. Zhou, and X. Wan. 2017. Applications of chitosan nanoparticles to enhance absorption and bioavailability of tea polyphenols: A review. Food Hydrocolloids. 69:286–92. doi: 10.1016/j.foodhyd.2017.01.041.
   Web of Science ®Google Scholar
• Lin, L., L. Zeng, A. Liu, Y. Peng, D. Yuan, S. Zhang, Y. Li, J. Chen, W. Xiao, and Z. Gong. 2020. L-Theanine regulates glucose, lipid, and protein metabolism via insulin and AMP-activated protein kinase signaling pathways. Food & Function 11 (2):1798–809. doi: 10.1039/C9FO02451D.
   PubMed Web of Science ®Google Scholar
• Liu, J., W. Hao, Z. He, E. Kwek, Y. Zhao, H. Zhu, N. Liang, K. Y. Ma, L. Lei, W.-S. He, et al. 2019. Beneficial effects of tea water extracts on the body weight and gut microbiota in C57BL/6J mice fed with a high-fat diet. Food & Function 10 (5):2847–60. doi: 10.1039/C8FO02051E.
   PubMed Web of Science ®Google Scholar
• Liu, S. H., J. Li, J. A. Huang, Z. H. Liu, and L. G. Xiong. 2021. New advances in genetic engineering for L-theanine biosynthesis. Trends in Food Science & Technology 114 (August):540–51. doi: 10.1016/j.tifs.2021.06.006.
   Google Scholar
• Liu, X., X. Du, G. Han, and W. Gao. 2017. Association between tea consumption and risk of cognitive disorders: A dose-response meta-analysis of observational studies. Oncotarget 8 (26):43306–21. doi: 10.18632/oncotarget.17429.
   PubMedGoogle Scholar
• London, E., and C. A. Stratakis. 2022. The regulation of PKA signaling in obesity and in the maintenance of metabolic health. Pharmacology & Therapeutics 237:108113. doi: 10.1016/j.pharmthera.2022.108113.
   PubMed Web of Science ®Google Scholar
• Londzin, P., M. Zamora, B. Kąkol, A. Taborek, and J. Folwarczna. 2021. Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies. Nutrients 13 (2):537 doi:10.3390/nu13020537.
   PubMed Web of Science ®Google Scholar
• Lu, H., X. Meng, and C. S. Yang. 2003. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. Drug Metabolism and Disposition: The Biological Fate of Chemicals 31 (5):572–9. doi: 10.1124/dmd.31.5.572.
   PubMed Web of Science ®Google Scholar
• Luo, M., R.-Y. Gan, B.-Y. Li, Q.-Q. Mao, A. Shang, X.-Y. Xu, H.-Y. Li, and H.-B. Li. 2021. Effects and mechanisms of tea on Parkinson’s disease, Alzheimer’s disease and depression. Food Reviews International: 1–29. doi: 10.1080/87559129.2021.1904413.
   Web of Science ®Google Scholar
• Ma, Q.-P., H. Chen, C. Qiao-Yun, Y. Ding-Jun, S. Kang, C. Xuan, and L. Xing-Hui. 2016. Meta-analysis of the association between tea intake and the risk of cognitive disorders. PloS One 11 (11): e0165861. doi: 10.1371/JOURNAL.PONE.0165861.
   PubMed Web of Science ®Google Scholar
• Maia, L., and A. De Mendonça. 2002. Does caffeine intake protect from Alzheimer’s disease? European Journal of Neurology 9 (4):377–82. doi: 10.1046/j.1468-1331.2002.00421.x.
   PubMed Web of Science ®Google Scholar
• Majolo, F. A. Martins, S. Rehfeldt, J. A. P. Henriques, V. Contini, and M. I. Goettert. 2021. Chapter 1 - Approaches for the treatment of neurodegenerative diseases related to natural products. In Bioactive natural products, edited by Atta-ur-Rahman, vol. 69, 1–63. Studies in natural products chemistry. The Netherlands: Elsevier. doi: 10.1016/B978-0-12-819487-4.00014-8.
   Google Scholar
• Makhaeva, G. F., S. V. Lushchekina, N. P. Boltneva, V. B. Sokolov, V. V. Grigoriev, O. G. Serebryakova, E. A. Vikhareva, A. Y. Aksinenko, G. E. Barreto, G. Aliev, et al. 2015. Conjugates of γ-carbolines and phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer disease. Scientific Reports 5 (1):13164–11. doi: 10.1038/srep13164.
   PubMedGoogle Scholar
• Marizzoni, M., S. Provasi, A. Cattaneo, and G. B. Frisoni. 2017. Microbiota and neurodegenerative diseases. Current Opinion in Neurology 30 (6):630–8. https://journals.lww.com/co-neurology/Fulltext/2017/12000/Microbiota_and_neurodegenerative_diseases.12.aspx. doi: 10.1097/WCO.0000000000000496.
   PubMed Web of Science ®Google Scholar
• Meco, A. D., C. De Lucia, M. E. Curtis, and D. Pratico. 2018. Gestational high sugar diet promotes Alzheimer’s disease phenotype, triggers metabolic dysfunction and shortens survival in 3XTG offspring later in life. Alzheimer’s & Dementia 14 (7, Supplement):P308. doi: 10.1016/j.jalz.2018.06.099.
   Google Scholar
• Mindt, M., T. Walter, P. Kugler, and V. F. Wendisch. 2020. Microbial engineering for production of N-functionalized amino acids and amines. Biotechnology Journal 15 (7):1900451–15. doi: 10.1002/biot.201900451.
   Web of Science ®Google Scholar
• Moreira, P. I., C. Carvalho, X. Zhu, M. A. Smith, and G. Perry. 2010. Mitochondrial dysfunction is a trigger of Alzheimer’s disease pathophysiology. Biochimica et Biophysica Acta 1802 (1):2–10. doi: 10.1016/J.BBADIS.2009.10.006.
   PubMed Web of Science ®Google Scholar
• Moro, S., F. Deflorian, G. Spalluto, G. Pastorin, B. Cacciari, S. K. Kim, and K. A. Jacobson. 2003. Demystifying the three dimensional structure of G protein-coupled receptors (GPCRs) with the aid of molecular modeling. Chemical Communications 3 (24):2949–56. doi: 10.1039/b303439a.
   Google Scholar
• Murakami, A. 2014. Dose-dependent functionality and toxicity of green tea polyphenols in experimental rodents. Archives of Biochemistry and Biophysics 557:3–10. doi: 10.1016/j.abb.2014.04.018.
   PubMed Web of Science ®Google Scholar
• Murphy, M. P., and H. Levine. 2010. Alzheimer’s disease and the amyloid-beta peptide. Journal of Alzheimer’s Disease: JAD 19 (1):311–23. doi: 10.3233/JAD-2010-1221.
   PubMed Web of Science ®Google Scholar
• Murray, M. T. 2020. 108 - Pyrroloquinoline Quinone (PQQ). In Textbook of natural medicine, edited by Joseph E Pizzorno and Michael T Murray, 5th ed., 833–5.e1. St. Louis, MO: Churchill Livingstone. doi: 10.1016/B978-0-323-43044-9.00108-4.
   Google Scholar
• Nehlig, A. 2018. Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacological Reviews 70 (2):384–411. doi: 10.1124/pr.117.014407.
   PubMed Web of Science ®Google Scholar
• Newman, D. J., and G. M. Cragg. 2016. Natural products as sources of new drugs from 1981 to 2014. Journal of Natural Products 79 (3):629–61. doi: 10.1021/acs.jnatprod.5b01055.
   PubMed Web of Science ®Google Scholar
• Ning, J. M., D. X. Li, X. J. Luo, D. Ding, Y. S. Song, Z. Z. Zhang, and X. C. Wan. 2016. Stepwise identification of six tea (Camellia Sinensis (L.)) categories based on catechins, caffeine, and theanine contents combined with fisher discriminant analysis. Food Analytical Methods 9 (11):3242–50. doi: 10.1007/s12161-016-0518-2.
   Web of Science ®Google Scholar
• Noguchi-Shinohara, M., S. Yuki, C. Dohmoto, Y. Ikeda, M. Samuraki, K. Iwasa, M. Yokogawa, et al. 2014. Consumption of green tea, but not black tea or coffee, is associated with reduced risk of cognitive decline. PloS One 9 (5):e96013–e96013. doi: 10.1371/journal.pone.0096013.
   Web of Science ®Google Scholar
• Okello, E. J., and J. Mather. 2020. Comparative kinetics of acetyl- and butyryl-cholinesterase inhibition by green tea catechins|relevance to the symptomatic treatment of Alzheimer’s disease. Nutrients 12(4): 1090. doi: 10.3390/nu12041090.
   PubMed Web of Science ®Google Scholar
• Park, K.-S., J. H. Oh, H.-S. Yoo, Y.-M. Lee, M.-K. Lee, J. T. Hong, and K.-W. Oh. 2010. (-)-Epigallocatechin-3-O-gallate (EGCG) reverses caffeine-induced anxiogenic-like effects. Neuroscience Letters 481 (2):131–4. doi: 10.1016/j.neulet.2010.06.072.
   PubMed Web of Science ®Google Scholar
• Park, S., D. S. Kim, S. Kang, and H. J. Kim. 2018. The combination of luteolin and L-theanine Improved Alzheimer disease-like symptoms by potentiating hippocampal insulin signaling and decreasing neuroinflammation and norepinephrine degradation in amyloid-β-infused rats. Nutrition Research (New York, NY) 60:116–31. doi: 10.1016/j.nutres.2018.09.010.
   PubMed Web of Science ®Google Scholar
• Pasinetti, G. M., and J. A. Eberstein. 2008. Metabolic syndrome and the role of dietary lifestyles in Alzheimer’s disease. Journal of Neurochemistry 106 (4):1503–14. doi: 10.1111/j.1471-4159.2008.05454.x.
   PubMed Web of Science ®Google Scholar
• Prasanth, M. I., B. S. Sivamaruthi, C. Chaiyasut, and T. Tencomnao. 2019. A review of the role of green tea (Camellia sinensis) in antiphotoaging, stress resistance, neuroprotection, and autophagy. Nutrients 11 (2):474. doi: 10.3390/nu11020474.
   PubMed Web of Science ®Google Scholar
• Przybylska, S. 2020. Lycopene – a bioactive carotenoid offering multiple health benefits: a review. International Journal of Food Science & Technology 55 (1):11–32. doi: 10.1111/ijfs.14260.
   Web of Science ®Google Scholar
• Pohanka, M., and P. Dobes. 2013. Caffeine inhibits acetylcholinesterase, but not butyrylcholinesterase. International Journal of Molecular Sciences 14 (5):9873–82. doi: 10.3390/ijms14059873.
   PubMed Web of Science ®Google Scholar
• Qian, X., X. Song, X. Liu, S. Chen, and H. Tang. 2021. Inflammatory pathways in Alzheimer’s disease mediated by gut microbiota. Ageing Research Reviews 68:101317. doi: 10.1016/j.arr.2021.101317.
   PubMed Web of Science ®Google Scholar
• Raber, J., Y. Huang, and J. W. Ashford. 2004. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiology of Aging 25 (5):641–50. doi: 10.1016/j.neurobiolaging.2003.12.023.
   PubMed Web of Science ®Google Scholar
• Radi, E., P. Formichi, C. Battisti, and A. Federico. 2014. Apoptosis and oxidative stress in neurodegenerative diseases. Journal of Alzheimer’s Disease 42 (s3):S125–S52. doi: 10.3233/JAD-132738.
   PubMedGoogle Scholar
• Rajendran, P., A. Bhatt, S. Manthuruthil, and S. Pericherla. 2013. Caffeine and Alzheimer’s Disease. International Journal of Biological & Medical Research 3 (1):3513–4. doi: 10.1016/S0140-6736(05)62266-0.
   Google Scholar
• Ramis, M. R., F. Sarubbo, S. Tejada, M. Jiménez, S. Esteban, A. Miralles, and D. Moranta. 2020. Chronic polyphenon-60 or catechin treatments increase brain monoamines syntheses and Hippocampal SIRT1 LEVELS improving cognition in aged rats. Nutrients 12(2): 326. doi: 10.3390/nu12020326.
   Web of Science ®Google Scholar
• Rashidinejad, A., S. Boostani, A. Babazadeh, A. Rehman, A. Rezaei, S. Akbari-Alavijeh, R. Shaddel, and S. M. Jafari. 2021. Opportunities and Challenges for the nanodelivery of green tea catechins in functional foods. Food Research International (Ottawa, ON) 142:110186. doi: 10.1016/j.foodres.2021.110186.
   PubMed Web of Science ®Google Scholar
• Reddy, P. H., M. Manczak, X. Yin, M. C. Grady, A. Mitchell, S. Tonk, C. S. Kuruva, et al. 2018. Protective effects of indian spice curcumin against amyloid-β in Alzheimer’s disease. Journal of Alzheimer’s Disease 61:843–66. doi: 10.3233/JAD-170512.
   PubMed Web of Science ®Google Scholar
• Rezai-Zadeh, K., G. W. Arendash, H. Hou, F. Fernandez, M. Jensen, M. Runfeldt, R. D. Shytle, and J. Tan. 2008. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Research 1214 (June):177–87. doi: 10.1016/J.BRAINRES.2008.02.107.
   PubMedGoogle Scholar
• Ritchie, K., I. Carrière, A. De Mendonça, F. Portet, J. F. Dartigues, O. Rouaud, P. Barberger-Gateau, and M. L. Ancelin. 2007. The neuroprotective effects of caffeine: A prospective population study (the three city study). Neurology 69 (6):536–45. doi: 10.1212/01.WNL.0000266670.35219.0C.
   PubMed Web of Science ®Google Scholar
• Rollins, C. P. E., D. Gallino, V. Kong, G. Ayranci, G. A. Devenyi, J. Germann, and M. M. Chakravarty. 2019. Contributions of a high-fat diet to Alzheimer’s disease-related decline: A longitudinal behavioural and structural neuroimaging study in mouse models. NeuroImage. Clinical 21:101606. doi: 10.1016/j.nicl.2018.11.016.
   PubMed Web of Science ®Google Scholar
• Roowi, S., A. Stalmach, W. Mullen, M. E. J. Lean, C. A. Edwards, and A. Crozier. 2010. Green tea flavan-3-ols: Colonic degradation and urinary excretion of catabolites by humans. Journal of Agricultural and Food Chemistry 58 (2):1296–304. doi: 10.1021/jf9032975.
   PubMed Web of Science ®Google Scholar
• La Rosa, F., M. Clerici, D. Ratto, A. Occhinegro, A. Licito, M. Romeo, C. Iorio, and P. Rossi. 2018. The gut-brain axis in Alzheimer’s disease and omega-3. A critical overview of clinical trials. Nutrients 10 (9):1267. doi: 10.3390/nu10091267.
   PubMed Web of Science ®Google Scholar
• Roux, P. P., and J. Blenis. 2004. ERK and P38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions. Microbiology and Molecular Biology Reviews: MMBR 68 (2):320–44. doi: 10.1128/MMBR.68.2.320-344.2004.
   PubMed Web of Science ®Google Scholar
• Roy, U., L. Stute, C. Höfling, M. Hartlage-Rübsamen, J. Matysik, S. Roβner, and A. Alia. 2018. Sex- and age-specific modulation of brain GABA levels in a mouse model of Alzheimer’s disease. Neurobiology of Aging 62:168–79. doi: 10.1016/j.neurobiolaging.2017.10.015.
   PubMed Web of Science ®Google Scholar
• Scapagnini, G., S. Vasto, V. Sonya, N. G. Abraham, A. G. Nader, C. Caruso, C. Calogero, D. Zella, and G. Fabio. 2011. Modulation of Nrf2/ARE pathway by food polyphenols: A nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Molecular Neurobiology 44 (2):192–201. doi: 10.1007/s12035-011-8181-5.
   PubMed Web of Science ®Google Scholar
• Scheid, L., S. Ellinger, B. Alteheld, H. Herholz, J. Ellinger, T. Henn, H. P. Helfrich, and P. Stehle. 2012. Kinetics of L-theanine uptake and metabolism in healthy participants are comparable after ingestion of L-theanine via capsules and green tea. The Journal of Nutrition 142 (12):2091–6. doi: 10.3945/jn.112.166371.
   PubMed Web of Science ®Google Scholar
• Seneff, S., G. Wainwright, and L. Mascitelli. 2011. Nutrition and Alzheimer’s disease: The detrimental role of a high carbohydrate diet. European Journal of Internal Medicine 22 (2):134–40. doi: 10.1016/j.ejim.2010.12.017.
   PubMed Web of Science ®Google Scholar
• Shal, B., W. Ding, H. Ali, Y. S. Kim, and S. Khan. 2018. Anti-neuroinflammatory potential of natural products in attenuation of Alzheimer’s disease. Frontiers in Pharmacology 9:548. doi: 10.3389/fphar.2018.00548.
   PubMed Web of Science ®Google Scholar
• Sharma, E., R. Joshi, and A. Gulati. 2018. L-Theanine: An astounding sui generis integrant in tea. Food Chemistry 242:601–10. doi: 10.1016/j.foodchem.2017.09.046.
   PubMed Web of Science ®Google Scholar
• Sharma, V. K., A. Bhattacharya, A. Kumar, and H. K. Sharma. 2007. Health benefits of tea consumption. Tropical Journal of Pharmaceutical Research 6 (3):785–92. doi: 10.4314/tjpr.v6i3.14660.
   Web of Science ®Google Scholar
• Shen, W., Y. Xiao, X. Ying, S. Li, Y. Zhai, X. Shang, F. Li, X. Wang, F. He, and J. Lin. 2015. Tea consumption and cognitive impairment: A cross-sectional study among Chinese elderly. PLoS One 10 (9):e0137781. doi: 10.1371/journal.pone.0137781.
   PubMed Web of Science ®Google Scholar
• Singh, N. A., A. K. A. Mandal, and Z. A. Khan. 2015. Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG). Nutrition Journal 15 (1). doi: 10.1186/s12937-016-0179-4.
   Google Scholar
• Singh, N. A., V. Bhardwaj, C. Ravi, N. Ramesh, A. K. A. Mandal, and Z. A. Khan. 2018. EGCG Nanoparticles attenuate aluminum chloride induced neurobehavioral deficits, beta amyloid and tau pathology in a rat model of Alzheimer’s disease. Frontiers in Aging Neuroscience 10. doi: 10.3389/fnagi.2018.00244.
   Web of Science ®Google Scholar
• Skrzypczak-Jankun, E., and J. Jankun. 2010. Theaflavin digallate inactivates plasminogen activator inhibitor: Could tea help in Alzheimer’s disease and obesity? International Journal of Molecular Medicine 26 (1):45–50. doi: 10.3892/ijmm_00000433.
   PubMed Web of Science ®Google Scholar
• Smith, A., B. Giunta, P. C. Bickford, M. Fountain, J. Tan, and R. D. Shytle. 2010. Nanolipidic Particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer’s disease. International Journal of Pharmaceutics 389 (1–2):207–12. doi: 10.1016/j.ijpharm.2010.01.012.
   PubMed Web of Science ®Google Scholar
• Solch, R. J., J. O. Aigbogun, A. G. Voyiadjis, G. M. Talkington, R. M. Darensbourg, S. O’Connell, K. M. Pickett, S. R. Perez, and D. M. Maraganore. 2022. Mediterranean diet adherence, gut microbiota, and Alzheimer’s or Parkinson’s disease risk: A systematic review. Journal of the Neurological Sciences 434:120166. doi: 10.1016/j.jns.2022.120166.
   PubMed Web of Science ®Google Scholar
• Spencer, J. P., H. Schroeter, A. R. Rechner, and C. Rice-Evans. 2001. Bioavailability of flavan-3-ols and procyanidins: Gastrointestinal tract influences and their relevance to bioactive forms in vivo. Antioxidants & Redox Signaling 3 (6):1023–39. doi: 10.1089/152308601317203558.
   PubMed Web of Science ®Google Scholar
• Stoothoff, W. H., and G. V. W. Johnson. 2005. Tau phosphorylation: Physiological and pathological consequences. Biochimica et Biophysica Acta 1739 (2–3):280–97. doi: 10.1016/j.bbadis.2004.06.017.
   PubMed Web of Science ®Google Scholar
• Strooper, B. D. 2010. Proteases and proteolysis in Alzheimer disease: A multifactorial view on the disease process. Physiological Reviews 90 (2):465–494. doi: 10.1152/physrev.00023.2009.
   Google Scholar
• Suganthy, N., and K. P. Devi. 2016. Protective effect of catechin rich extract of rhizophora mucronata against β-amyloid-induced toxicity in PC12 cells. Journal of Applied Biomedicine 14 (2):137–46. doi: 10.1016/j.jab.2015.10.003.
   Web of Science ®Google Scholar
• Sun, H., Y. Chen, M. Cheng, X. Zhang, X. Zheng, and Z. Zhang. 2018. The modulatory effect of polyphenols from green tea, oolong tea and black tea on human intestinal microbiota in vitro. Journal of Food Science and Technology 55 (1):399–407. doi: 10.1007/s13197-017-2951-7.
   PubMed Web of Science ®Google Scholar
• Swerdlow, R. H., J. M. Burns, and S. M. Khan. 2014. The Alzheimer’s disease mitochondrial cascade hypothesis: Progress and perspectives. Biochimica et Biophysica Acta 1842 (8):1219–31. doi: 10.1016/j.bbadis.2013.09.010.
   PubMed Web of Science ®Google Scholar
• Swerdlow, R. H., and S. M. Khan. 2004. A “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease. Medical Hypotheses 63 (1):8–20. doi: 10.1016/j.mehy.2003.12.045.
   PubMed Web of Science ®Google Scholar
• Taniguchi, S., N. Suzuki, M. Masuda, S. I. Hisanaga, T. Iwatsubo, M. Goedert, and M. Hasegawa. 2005. Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. The Journal of Biological Chemistry 280 (9):7614–23. doi: 10.1074/JBC.M408714200.
   PubMed Web of Science ®Google Scholar
• Temple, J. L., C. Bernard, S. E. Lipshultz, J. D. Czachor, J. A. Westphal, and M. A. Mestre. 2017. The safety of ingested caffeine: A comprehensive review. Frontiers in Psychiatry 8 (May):80. doi:10.3389/FPSYT.2017.00080/BIBTEX.
   PubMedGoogle Scholar
• Tomata, Y., K. Sugiyama, Y. Kaiho, K. Honkura, T. Watanabe, S. Zhang, Y. Sugawara, and I. Tsuji. 2016. Green tea consumption and the risk of incident dementia in elderly Japanese: The Ohsaki cohort 2006 study. The American Journal of Geriatric Psychiatry 24 (10):881–9. doi: 10.1016/j.jagp.2016.07.009.
   PubMed Web of Science ®Google Scholar
• Tomata, Y., M. Kakizaki, N. Nakaya, T. Tsuboya, T. Sone, S. Kuriyama, A. Hozawa, and I. Tsuji. 2012. Green tea consumption and the risk of incident functional disability in elderly Japanese: The Ohsaki Cohort 2006 study. The American Journal of Clinical Nutrition 95 (3):732–39. doi: 10.3945/ajcn.111.023200.
   PubMed Web of Science ®Google Scholar
• Türközü, D., and N. Şanlier. 2017. L-Theanine, unique amino acid of tea, and its metabolism, health effects, and safety. Critical Reviews in Food Science and Nutrition 57 (8):1681–7. doi: 10.1080/10408398.2015.1016141.
   PubMed Web of Science ®Google Scholar
• Unno, T., Y. Suzuki, T. Kakuda, T. Hayakawa, and H. Tsuge. 1999. Metabolism of theanine, gamma-glutamylethylamide, in rats. Journal of Agricultural and Food Chemistry 47 (4):1593–6. doi: 10.1021/jf981113t.
   PubMed Web of Science ®Google Scholar
• van der Pijl, P. C., L. Chen, and T. P. J. Mulder. 2010. Human disposition of L-theanine in tea or aqueous solution. Journal of Functional Foods 2 (4):239–44. doi: 10.1016/j.jff.2010.08.001.
   Web of Science ®Google Scholar
• Vuong, Q. V. 2014. Epidemiological evidence linking tea consumption to human health: A review. Critical Reviews in Food Science and Nutrition 54 (4):523–36. doi: 10.1080/10408398.2011.594184.
   PubMed Web of Science ®Google Scholar
• Vuong, Q. V., M. C. Bowyer, and P. D. Roach. 2011. L-Theanine: Properties, synthesis and isolation from tea. Journal of the Science of Food and Agriculture 91 (11):1931–9. doi: 10.1002/jsfa.4373.
   PubMed Web of Science ®Google Scholar
• Walker, J. M., D. Klakotskaia, D. Ajit, G. A. Weisman, W. G. Wood, G. Y. Sun, P. Serfozo, A. Simonyi, and T. R. Schachtman. 2015. Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer’s disease mouse model. Journal of Alzheimer’s Disease 44:561–72. doi: 10.3233/JAD-140981.
   PubMed Web of Science ®Google Scholar
• Wei, Y., J. Xu, S. W. Miao, K. Wei, L. L. Peng, Y. F. Wang, and X. L. Wei. 2022. Recent advances in the utilization of tea active ingredients to regulate sleep through neuroendocrine pathway, immune system and intestinal microbiota. Critical Reviews in Food Science and Nutrition 1–29. doi: 10.1080/10408398.2022.2048291.
   Web of Science ®Google Scholar
• Więckowska-Gacek, A., A. Mietelska-Porowska, M. Wydrych, and U. Wojda. 2021. Western diet as a trigger of Alzheimer’s disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration. Ageing Research Reviews 70:101397. doi: 10.1016/j.arr.2021.101397.
   PubMed Web of Science ®Google Scholar
• Wong, M., S. Sirisena, and K. Ng. 2022. Phytochemical profile of differently processed tea: A review. Journal of Food Science 87 (5):1925–42. doi: 10.1111/1750-3841.16137.
   PubMed Web of Science ®Google Scholar
• Wood, E. K., and E. L. Sullivan. 2022. The influence of diet on metabolism and health across the lifespan in nonhuman primates. Current Opinion in Endocrine and Metabolic Research 24:100336. doi: 10.1016/j.coemr.2022.100336.
   PubMedGoogle Scholar
• Xia, H., J. Wang, X. Xie, L. Xu, and S. Tang. 2019. Green tea polyphenols attenuate hepatic steatosis, and reduce insulin resistance and inflammation in high-fat diet-induced rats. International Journal of Molecular Medicine 44 (4):1523–30. doi: 10.3892/ijmm.2019.4285.
   PubMed Web of Science ®Google Scholar
• Xu, H., Y. Wang, Y. Yuan, X. Zhang, X. Zuo, L. Cui, Y. Liu, et al. 2018. Gender differences in the protective effects of green tea against amnestic mild cognitive impairment in the elderly Han population. Neuropsychiatric Disease and Treatment 14 (July):1795–801. doi: 10.2147/NDT.S165618.
   PubMedGoogle Scholar
• Yamada, T., T. Terashima, H. Honma, S. Nagata, T. Okubo, L. R. Juneja, and H. Yokogoshi. 2008. Effects of theanine, a unique amino acid in tea leaves, on memory in a rat behavioral test. Bioscience, Biotechnology, and Biochemistry 72 (5):1356–9. doi: 10.1271/bbb.70669.
   PubMed Web of Science ®Google Scholar
• Yamamoto, N., M. Shibata, R. Ishikuro, M. Tanida, Y. Taniguchi, Y. Ikeda-Matsuo, and K. Sobue. 2017. Epigallocatechin gallate induces extracellular degradation of amyloid β-protein by increasing neprilysin secretion from astrocytes through activation of ERK and PI3K pathways. Neuroscience 362:70–8. doi: 10.1016/j.neuroscience.2017.08.030.
   PubMed Web of Science ®Google Scholar
• Yang, C. S., and E. Pan. 2012. The effects of green tea polyphenols on drug metabolism. Expert Opinion on Drug Metabolism & Toxicology 8 (6):677–89. doi: 10.1517/17425255.2012.681375.
   PubMed Web of Science ®Google Scholar
• Yang, C. S., X. Wang, G. Lu, and S. C. Picinich. 2009. Cancer prevention by tea: Animal studies, molecular mechanisms and human n relevance. Nature Reviews. Cancer 9 (6):429–39. doi: 10.1038/nrc2641.
   PubMed Web of Science ®Google Scholar
• Yang, L., X. Jin, J. Yan, Y. Jin, W. Yu, H. Wu, and S. Xu. 2016. Prevalence of dementia, cognitive status and associated risk factors among elderly of Zhejiang Province, China in 2014. Age and Ageing 45 (5):707–11. doi: 10.1093/ageing/afw088.
   Web of Science ®Google Scholar
• Yang, S., W. Liu, S. Lu, Y. Tian, W. Wang, T. Ling, and R. Liu. 2016. A novel multifunctional compound camellikaempferoside B decreases Aβ production, interferes with Aβ aggregation, and prohibits Aβ-mediated neurotoxicity and neuroinflammation. ACS Chemical Neuroscience 7 (4):505–18. doi: 10.1021/acschemneuro.6b00091.
   PubMed Web of Science ®Google Scholar
• Yang, W., D. Ren, Y. Zhao, L. Liu, and X. Yang. 2021. Fuzhuan brick tea polysaccharide improved ulcerative colitis in association with gut microbiota-derived tryptophan metabolism. Journal of Agricultural and Food Chemistry 69 (30):8448–59. doi: 10.1021/acs.jafc.1c02774.
   PubMed Web of Science ®Google Scholar
• Yang, Z., D.-D. Zhou, S.-Y. Huang, A.-P. Fang, H.-B. Li, and H.-L. Zhu. 2021. Effects and mechanisms of natural products on Alzheimer’s disease. Critical Reviews in Food Science and Nutrition: 1–21. doi: 10.1080/10408398.2021.1985428.
   Web of Science ®Google Scholar
• Yang, L., X. Jin, J. Yan, Y. Jin, W. Yu, H. Wu, and S. Xu. 2016. Prevalence of dementia, cognitive status and associated risk factors among elderly of Zhejiang Province, China in 2014. Age and Ageing 45 (5): 707–11. doi: 10.1093/AGEING/AFW088.
   Web of Science ®Google Scholar
• Yang, S., W. Liu, S. Lu, Y. Tian, W. Wang, T. Ling, and R. Liu. 2016. A novel multifunctional compound camellikaempferoside B decreases Aβ production, interferes with Aβ aggregation, and prohibits Aβ-mediated neurotoxicity and neuroinflammation. ACS Chemical Neuroscience 7 (4): 505–18. doi: 10.1021/acschemneuro.6b00091.
   PubMed Web of Science ®Google Scholar
• Yang, W., D. Ren, Y. Zhao, L. Liu, and X. Yang. 2021. Fuzhuan brick tea polysaccharide improved ulcerative colitis in association with gut microbiota-derived tryptophan metabolism. Journal of Agricultural and Food Chemistry 69 (30): 8448–59. doi: 10.1021/acs.jafc.1c02774.
   Web of Science ®Google Scholar
• Yazir, Y., T. Utkan, N. Gacar, and F. Aricioglu. 2015. Resveratrol exerts anti-inflammatory and neuroprotective effects to prevent memory deficits in rats exposed to chronic unpredictable mild stress. Physiology & Behavior 138:297–304. doi: 10.1016/j.physbeh.2014.10.010.
   PubMed Web of Science ®Google Scholar
• Yenisetti, S. C., and Y. Muralidhara. 2016. Beneficial role of coffee and caffeine in neurodegenerative diseases: A minireview. AIMS Public Health 3 (2):407–22. doi: 10.3934/publichealth.2016.2.407.
   PubMedGoogle Scholar
• Yi, T., L. Zhu, W.-L. Peng, X.-C. He, H.-L. Chen, J. Li, T. Yu, Z.-T. Liang, Z.-Z. Zhao, and H.-B. Chen. 2015. Comparison of ten major constituents in seven types of processed tea using HPLC-DAD-MS followed by principal component and hierarchical cluster analysis. LWT - Food Science and Technology 62 (1):194–201. doi: 10.1016/j.lwt.2015.01.003.
   Web of Science ®Google Scholar
• Yu, Z., and Z. Yang. 2020. Understanding different regulatory mechanisms of proteinaceous and non-proteinaceous amino acid formation in tea (Camellia sinensis) provides new insights into the safe and effective alteration of tea flavor and function. Critical Reviews in Food Science and Nutrition 60 (5):844–58. doi: 10.1080/10408398.2018.1552245.
   PubMed Web of Science ®Google Scholar
• Yusufov, M., L. L. Weyandt, and I. Piryatinsky. 2017. Alzheimer’s disease and diet: A systematic review. International Journal of Neuroscience 127 (2):161–75. doi: 10.3109/00207454.2016.1155572.
   PubMed Web of Science ®Google Scholar
• Zappettini, S., E. Faivre, A. Ghestem, S. Carrier, L. Buée, D. Blum, M. Esclapez, and C. Bernard. 2019. Caffeine consumption during pregnancy accelerates the development of cognitive deficits in offspring in a model of tauopathy. Frontiers in Cellular Neuroscience 13. doi: 10.3389/fncel.2019.00438.
   Web of Science ®Google Scholar
• Zeitlin, R., S. Patel, S. Burgess, G. W. Arendash, and V. Echeverria. 2011. Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer’s transgenic mice. Brain Research 1417:127–36. doi: 10.1016/j.brainres.2011.08.036.
   PubMed Web of Science ®Google Scholar
• Zhang, C., C. L.-C. Suen, C. Yang, and S. Y. Quek. 2018. Antioxidant capacity and major polyphenol composition of teas as affected by geographical location, plantation elevation and leaf grade. Food Chemistry 244:109–19. doi: 10.1016/j.foodchem.2017.09.126.
   PubMed Web of Science ®Google Scholar
• Zhang, X., X. Zhu, Y. Sun, B. Hu, Y. Sun, S. Jabbar, and X. Zeng. 2013. Fermentation in vitro of EGCG, GCG and EGCG3”Me isolated from Oolong tea by human intestinal microbiota. Food Research International 54 (2):1589–95. doi: 10.1016/j.foodres.2013.10.005.
   Web of Science ®Google Scholar
• Zhang, Y., C. Chen, Y. Jiang, S. Wang, X. Wu, and K. Wang. 2017. PPARγ coactivator-1α (PGC-1α) protects neuroblastoma cells against amyloid-beta (Aβ) induced cell death and neuroinflammation via NF-ΚB pathway. BMC Neuroscience 18 (1):69. doi: 10.1186/s12868-017-0387-7.
   PubMedGoogle Scholar
• Zhang, Z., F. He, W. Yang, L. Yang, S. Huang, H. Mao, Y. Hou, and R. Xiao. 2021. Pu-Erh tea extraction alleviates intestinal ­inflammation in mice with flora disorder by regulating gut microbiota. Food Science & Nutrition 9 (9):4883–92. doi: 10.1002/fsn3.2437.
   Web of Science ®Google Scholar
• Zhang, J., A. Wang, X. Zhang, S. Chen, S. Wu, X. Zhao, and Q. Zhang. 2020. Association between tea consumption and cognitive impairment in middle-aged and older adults. BMC Geriatrics 20 (1):447. doi: 10.1186/s12877-020-01848-6.
   PubMed Web of Science ®Google Scholar
• Zhao, C.-N., G.-Y. Tang, S.-Y. Cao, X.-Y. Xu, R.-Y. Gan, Q. Liu, Q.-Q. Mao, A. Shang, and H.-B. Li. 2019. Phenolic profiles and antioxidant activities of 30 tea infusions from green, black, oolong, white, yellow and dark teas. Antioxidants 8 (7):215. doi: 10.3390/antiox8070215.
   Web of Science ®Google Scholar
• Zhong, X., M. Liu, W. Yao, K. Du, M. He, X. Jin, L. Jiao, G. Ma, B. Wei, and M. Wei. 2019. Epigallocatechin-3-gallate attenuates microglial inflammation and neurotoxicity by suppressing the activation of canonical and noncanonical inflammasome via TLR4/NF-ΚB pathway. Molecular Nutrition & Food Research 63 (21):1801230. doi: 10.1002/mnfr.201801230.
   PubMed Web of Science ®Google Scholar
• Zhou, X., and L. Zhang. 2021. The neuroprotective effects of moderate and regular caffeine consumption in Alzheimer’s disease. Oxidative Medicine and Cellular Longevity 2021:5568011. doi: 10.1155/2021/5568011.
   PubMed Web of Science ®Google Scholar
• Zhou, C., X. Zhou, Z. Wen, Z. Yang, R. Mu, Y. Song, X. Mei, and D. O. Rothenberg. 2021. Effect of Duyun compound green tea on gut microbiota diversity in high-fat-diet-induced mice revealed by illumina high-throughput sequencing. Edited by Chongshan Dai. Evidence-Based Complementary and Alternative Medicine 2021: 8832554. doi: 10.1155/2021/8832554.
   PubMed Web of Science ®Google Scholar
• Zhou, F., Y.-L. Li, X. Zhang, K.-B. Wang, J.-A. Huang, Z.-H. Liu, and M.-Z. Zhu. 2021. Polyphenols from Fu brick tea reduce obesity via modulation of gut microbiota and gut microbiota-related intestinal oxidative stress and barrier function. Journal of Agricultural and Food Chemistry 69 (48): 14530–43. doi: 10.1021/acs.jafc.1c04553.
   PubMed Web of Science ®Google Scholar
• Zhu, G., S. Yang, Z. Xie, and X. Wan. 2018. Synaptic modification by L-theanine, a natural constituent in green tea, rescues the impairment of hippocampal long-term potentiation and memory in AD mice. Neuropharmacology 138:331–40. doi: 10.1016/j.neuropharm.2018.06.030.
   PubMed Web of Science ®Google Scholar
• Zuo, A.-R., H.-H. Dong, Y.-Y. Yu, Q.-L. Shu, L.-X. Zheng, X.-Y. Yu, and S.-W. Cao. 2018. The Antityrosinase and antioxidant activities of flavonoids dominated by the number and location of phenolic hydroxyl groups. Chinese Medicine 13 (1):51. doi: 10.1186/s13020-018-0206-9.
   PubMedGoogle Scholar